Literature DB >> 12509389

Biological significance of interventions that change breast density.

Rowan T Chlebowski, Anne McTiernan.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12509389     DOI： 10.1093/jnci/95.1.4

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  9 in total

1.  CD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissues.

Authors:  Rosa Anna DeFilippis; Hang Chang; Nancy Dumont; Joseph T Rabban; Yunn-Yi Chen; Gerald V Fontenay; Hal K Berman; Mona L Gauthier; Jianxin Zhao; Donglei Hu; James J Marx; Judy A Tjoe; Elad Ziv; Maria Febbraio; Karla Kerlikowske; Bahram Parvin; Thea D Tlsty
Journal:  Cancer Discov       Date:  2012-07-09       Impact factor: 39.397

Review 2.  Progestins and progesterone in hormone replacement therapy and the risk of breast cancer.

Authors:  Carlo Campagnoli; Françoise Clavel-Chapelon; Rudolf Kaaks; Clementina Peris; Franco Berrino
Journal:  J Steroid Biochem Mol Biol       Date:  2005-07       Impact factor: 4.292

Review 3.  Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review.

Authors:  Emma C Atakpa; Mangesh A Thorat; Jack Cuzick; Adam R Brentnall
Journal:  Cochrane Database Syst Rev       Date:  2021-10-26

4.  Conjugated equine estrogen influence on mammographic density in postmenopausal women in a substudy of the women's health initiative randomized trial.

Authors:  Anne McTiernan; Rowan T Chlebowski; Christopher Martin; Jennifer David Peck; Aaron Aragaki; Etta D Pisano; C Y Wang; Karen C Johnson; Joann E Manson; Robert B Wallace; Mara Z Vitolins; Gerardo Heiss
Journal:  J Clin Oncol       Date:  2009-11-09       Impact factor: 44.544

5.  Parenchymal texture analysis in digital breast tomosynthesis for breast cancer risk estimation: a preliminary study.

Authors:  Despina Kontos; Predrag R Bakic; Ann-Katherine Carton; Andrea B Troxel; Emily F Conant; Andrew D A Maidment
Journal:  Acad Radiol       Date:  2009-03       Impact factor: 3.173

6.  Decreased TGFbeta signaling and increased COX2 expression in high risk women with increased mammographic breast density.

Authors:  Wei Tse Yang; Michael T Lewis; Kenneth Hess; Helen Wong; Anna Tsimelzon; Nese Karadag; Michelina Cairo; Caimaio Wei; Funda Meric-Bernstam; Powel Brown; Banu Arun; Gabriel N Hortobagyi; Aysegul Sahin; Jenny C Chang
Journal:  Breast Cancer Res Treat       Date:  2009-02-25       Impact factor: 4.872

7.  Mammographic parenchymal patterns as an imaging marker of endogenous hormonal exposure: a preliminary study in a high-risk population.

Authors:  Dania Daye; Brad Keller; Emily F Conant; Jinbo Chen; Mitchell D Schnall; Andrew D A Maidment; Despina Kontos
Journal:  Acad Radiol       Date:  2013-05       Impact factor: 3.173

Review 8.  Mammographic density: a potential monitoring biomarker for adjuvant and preventative breast cancer endocrine therapies.

Authors:  Michael S Shawky; Hilary Martin; Honor J Hugo; Thomas Lloyd; Kara L Britt; Andrew Redfern; Erik W Thompson
Journal:  Oncotarget       Date:  2017-01-17

9.  Agreement of mammographic measures of volumetric breast density to MRI.

Authors:  Jeff Wang; Ania Azziz; Bo Fan; Serghei Malkov; Catherine Klifa; David Newitt; Silaja Yitta; Nola Hylton; Karla Kerlikowske; John A Shepherd
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.